Literature DB >> 26697778

Chronic anosmia induces depressive behavior and reduced anxiety via dysregulation of glucocorticoid receptor and corticotropin-releasing hormone in a mouse model.

Sangzin Ahn1, Hyun-Woo Shin1, Usman Mahmood2, Roza Khalmuratova1, Sea-Yuong Jeon3, Hong Ryul Jin4, Jung-Seok Choi5, Hye-Sun Kim1, Dae Woo Kim4.   

Abstract

BACKGROUND: Olfactory loss is highly prevalent, and comorbid mood disorders are common. Considering olfactory input is highly interconnected with the limbic system, and that the limbic system manages mood, it is predictable that impairments in the sense of smell may result in mood changes.
METHODOLOGY: Chronic olfactory deficits were induced by repeated intranasal irrigation of ZnSO4 for 12 weeks in BALB/c mice. H&E staining, OMP staining, and potato chip finding test were performed to confirm olfactory loss. Tail suspension, forced swim, and splash tests were performed to evaluate depression, as well as open field, elevated plus maze tests were applied to assess anxiety. The mRNA levels of glucocorticoid receptor (GR) and corticotropin releasing hormone (CRH) were measured by real-time PCR to confirm relevant molecular changes.
RESULTS: Disruption of the olfactory epithelium and olfactory loss was confirmed in histological studies and potato chip finding test. Behavioral tests show that the chronic anosmic state caused increased depression and reduced anxiety. PCR data showed that mRNA levels of GR in the hypothalamus and CRH in the amygdala were significantly decreased.
CONCLUSIONS: These results propose that ZnSO4-induced chronic anosmia can cause a depressive and anxiolytic state via decreased hypothalamic GR and amygdalar CRH.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26697778     DOI: 10.4193/Rhino15.209

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  1 in total

1.  Affective Personality Traits in Olfactory Dysfunction: the Role of Dysthymia and Arousal.

Authors:  Anne Schienle; Axel Wolf; Peter Valentin Tomazic; Rottraut Ille
Journal:  Chemosens Percept       Date:  2017-12-14       Impact factor: 1.833

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.